871013-92-2 Usage
Description
Tert-butyl 4-hydroxyisoindoline-2-carboxylate is a chemical compound with the molecular formula C14H17NO4. It is an ester derivative of 4-hydroxyisoindoline-2-carboxylic acid, featuring a tert-butyl group attached to the nitrogen atom and a carboxylic acid group. tert-butyl 4-hydroxyisoindoline-2-carboxylate is known for its potential antioxidant and antitumor activities, as well as its unique structure and reactivity, which make it a valuable intermediate in the synthesis of various pharmaceuticals, agricultural chemicals, and specialty chemicals.
Uses
Used in Pharmaceutical Industry:
Tert-butyl 4-hydroxyisoindoline-2-carboxylate is used as a building block for the preparation of various pharmaceuticals due to its potential antioxidant and antitumor activities. Its unique structure and reactivity allow for the development of new drugs with improved therapeutic properties.
Used in Agricultural Chemical Industry:
In the agricultural chemical industry, tert-butyl 4-hydroxyisoindoline-2-carboxylate is utilized as a key intermediate in the synthesis of various agrochemicals, contributing to the development of effective and environmentally friendly products for crop protection and enhancement.
Used in Specialty Chemicals Production:
Tert-butyl 4-hydroxyisoindoline-2-carboxylate is employed as a valuable intermediate in the production of specialty chemicals, where its unique structure and reactivity play a crucial role in creating innovative and high-performance products for various applications.
Check Digit Verification of cas no
The CAS Registry Mumber 871013-92-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,1,0,1 and 3 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 871013-92:
(8*8)+(7*7)+(6*1)+(5*0)+(4*1)+(3*3)+(2*9)+(1*2)=152
152 % 10 = 2
So 871013-92-2 is a valid CAS Registry Number.
871013-92-2Relevant articles and documents
INHIBITORS OF MLH1 AND/OR PMS2 FOR CANCER TREATMENT
-
, (2021/12/28)
The present invention relates to compounds of Formula (I) that target the MLH1 and/or PMS2 proteins that are components of the DNA Mismatch Repair (MMR) process: Formula (I) wherein R1, R2, R3, R4, R6
RHO KINASE INHIBITORS
-
, (2015/04/28)
The invention provides novel inhibitors of ROCK1 and/or ROCK2. Also provided are methods of treating diseases and disorders involving inhibiting ROCK1 and/or ROCK2. The present invention includes pharmaceutical compositions comprising the compounds of the invention and a pharmaceutically acceptable carrier and/or diluents. The present invention includes compositions comprising a substantially pure compound of the invention and a pharmaceutically acceptable salt, steroisomer, or hydrate thereof: and a pharmaceutically acceptable excipient and/or diluents.